Live Breaking News & Updates on Denali Therapeutics

Stay updated with breaking news from Denali therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors

13.06.2024 - SOUTH SAN FRANCISCO, June 13, 2024 (GLOBE NEWSWIRE) - Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today . Seite 1 ....

Guardant Health , Harvard Business School , Mckinsey Company , Goldman Sachs , Wharton School Of The University Pennsylvania , Roche Holding , Chief Financial Officer , Denali Therapeutics , Global Head , Wharton School ,

Denali Therapeutics (NASDAQ:DNLI) Sees Large Volume Increase

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) shares saw strong trading volume on Wednesday . 2,015,233 shares traded hands during trading, an increase of 76% from the previous session’s volume of 1,148,126 shares.The stock last traded at $22.39 and had previously closed at $21.60. Wall Street Analyst Weigh In A number of equities research […] ....

United States , Stifel Nicolaus , Jennifere Cook , Vickil Sato , Securities Exchange Commission , Denali Therapeutics Inc , Assetmark Inc , Goldman Sachs Group , Denali Therapeutics Company Profile , Headlands Technologies , Financial Services Group Inc , Fisher Asset Management , Denali Therapeutics , Get Free Report , Director Jennifer , Exchange Commission , Director Vicki , Services Group , Asset Management , Therapeutics Inc , Denali Therapeutics Daily ,

Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) Director Sells 1,458 Shares of Stock

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) Director Jennifer E. Cook sold 1,458 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $21.73, for a total transaction of $31,682.34. Following the transaction, the director now owns 20,038 shares in the company, valued at […] ....

United States , Jennifere Cook , Stifel Nicolaus , Principal Financial Group Inc , Denali Therapeutics Inc , Denali Therapeutics Company Profile , Goldman Sachs Group , Norges Bank , Capital Research Global Investors , Denali Therapeutics , Get Free Report , Director Jennifer , Research Global Investors , Principal Financial Group , Financial Group , Therapeutics Inc , Denali Therapeutics Daily ,

What Endowments and Foundations Are Most Worried About Right Now

What Endowments and Foundations Are Most Worried About Right Now
institutionalinvestor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from institutionalinvestor.com Daily Mail and Mail on Sunday newspapers.

United States , Korro Bio , Goldman Sachs , Bain Co , Institutional Investor , Foundations Roundtable , Chatham House Rules , Deep Track Capital , Blue Owl , Rock Springs , Denali Therapeutics , West Coast ,

New therapeutic approach for frontotemporal dementia uses modified viruses to replace a missing protein in the brain

New therapeutic approach for frontotemporal dementia uses modified viruses to replace a missing protein in the brain
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

San Francisco , United States , Marvin Reich , Marvin Reich Kultivierte , Anja Capell , Dominik Paquet , Christian Haass , German Center , Biomedical Center , Dementia Research , Institute For Stroke , Neurodegenerative Diseases , Denali Therapeutics , Science Translational , Professor Dominik Paquet , Synergy Cluster , Professor Christian Haass , Science Translational Medicine ,